175153-55-6 Usage
Uses
Used in Pharmaceutical Industry:
2-CHLORO-4-MORPHOLINOBENZENECARBOXYLIC ACID is used as an intermediate in the synthesis of various pharmaceutical products for the treatment of different diseases and conditions. Its unique structure allows it to be a key component in the development of new drugs.
Used in Organic Synthesis:
2-CHLORO-4-MORPHOLINOBENZENECARBOXYLIC ACID is used as a reagent in organic synthesis, enabling the creation of a wide range of chemical compounds for various purposes.
Used in Specialty Chemicals Production:
2-CHLORO-4-MORPHOLINOBENZENECARBOXYLIC ACID is also utilized in the production of specialty chemicals, where its specific properties can be harnessed for unique applications.
Safety Precautions:
It is crucial to handle 2-CHLORO-4-MORPHOLINOBENZENECARBOXYLIC ACID with care, as it may possess hazardous properties. Proper safety precautions and regulations should be followed during its use to ensure the safety of individuals and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 175153-55-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,1,5 and 3 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 175153-55:
(8*1)+(7*7)+(6*5)+(5*1)+(4*5)+(3*3)+(2*5)+(1*5)=136
136 % 10 = 6
So 175153-55-6 is a valid CAS Registry Number.
175153-55-6Relevant academic research and scientific papers
COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF
-
Paragraph 00336, (2021/12/31)
The present invention relates to novel collagen translation inhibitors 1, a composition, their preparation methods, and their uses for the treatment of fibrosis in particular, fibrosis of the lung, liver, kidney, cardiac and dermal fibrosis, IPF, wound he
4,4-DIFLUORO-1,2,3,4-TETRAHYDRO-5H-1-BENZAZEPINE DERIVATIVES OR SALTS THEREOF
-
Page 20; 23, (2008/06/13)
4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivatives, which have excellent arginine vasopressin V2 activity and are useful for a drug for the treatment of central diabetes insipidus and/or nocturia.
Novel design of nonpeptide AVP V2 receptor agonists: Structural requirements for an agonist having 1-(4-aminobenzoyl)-2,3,4,5-tetrahydro-1H-1-benzazepine as a template
Kondo,Ogawa,Shinohara,Kurimura,Tanada,Kan,Yamashita,Nakamura,Hirano,Yamamura,Mori,Tominaga,Itai
, p. 4388 - 4397 (2007/10/03)
The discovery of a series of nonpeptide arginine vasopressin V2 receptor agonists is described. After identifying the aniline derivative 8 as our lead compound from the metabolites of compound 7 that showed antidiuretic activity by po administr
